Alzheimer Research Center

Amsterdam 1081 GM

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease

Studies at this site

• Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease — Completed
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early